MedPath

Pilot-testing of the Japanese version of EORTC QLQ-INFO25

Not Applicable
Conditions
Malignancy
Registration Number
JPRN-UMIN000020035
Lead Sponsor
Tohoku University Graduate School of Medicine, Division of Biostatistics
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
15
Inclusion Criteria

Not provided

Exclusion Criteria

1. Double cancer 2. Severe psychiatric disorder 3. Linguistic difficulty preventing patients from completing the questionnaires.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcomes associated with this study include the ability for the EORTC QLQ-INFO25 to be used in Japan with confidence that the Japanese items are translated correctly and are culturally meaningful and appropriate.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath